Heartseed, a spin-off of Keio University, targets iPS cell-derived cardiomyocytes for the treatment of heart insufficiency
Heartseed news release, July 30, 2018
Astellas corporate venture invests in Keio University’s Heartseed
Window to Japan
Window to Japan
Heartseed, a spin-off of Keio University, targets iPS cell-derived cardiomyocytes for the treatment of heart insufficiency
Heartseed news release, July 30, 2018